Angela Yee-MoonWang Hong Kong/SingaporeSingapore

Angela Yee-MoonWang
She is Clinical Professor of Duke-National University of Singapore Academic Medical Center, and Senior Consultant at Singapore General Hospital. She is the current Chair of ISN Education Working Group, ISN Councilor, and Chair of ISN North & East Asia Regional Board. She is also immediate Past President of International Society of Renal Nutrition and Metabolism (ISRNM), Council member of ISPD, Previous Exe Committee member of KDIGO. She is also a Committee Member of ISN-ACT, Exe Committee Member of SONG. She has served as a workgroup member of international clinical practice guidelines (CPG) including ISPD Prescribing High Quality Goal-Directed PD Guidelines 2020, ISPD-GREX Practice Recommendations on Physical Activity and Exercise in PD 2021 and KDOQI Nutrition Guidelines 2020 and KDIGO anemia guidelines in CKD 2022. She serves on the editorial board of ASN Journals, Kidney Int, NDT (theme Editor), Nephron Clinical Practice. She has received ISPD John Maher Award 2006 and NKF Joel D. Kopple Award 2018 and Thomas Addis Award, a lifetime award of the ISRNM in Dec 2022. She has published >240 papers, 15 book chapters, delivered >150 invited lectures in international meetings. She is recognized for her research in cardiovascular, metabolic and nutrition complications in CKD. She also works in clinical trials and innovations to improve outcomes of kidney patients.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/5c139ce61ab83640882655170255e622.jpg
First Name
Angela Yee-Moon
Last Name
Wang
Institution
Country.
Singapore

Sunday, February 9, 2025

Time Session
9:45 a.m.
11:15 a.m.
GloriaAshuntantang Chair gloria.ash60@gmail.comUniversity of Bamenda, CameroonCameroon
Narayan Prasad Chair narayan.nephro@gmail.comIndia
Dr Sree BhushanRaju Chair sreebhushan@hotmail.comIndia
  • Hepatorenal Syndrome and New Treatments for AKI in Cirrhosis
    Swetha RaniKanduri Speaker Ochsner Health, New Orleans, LAUnited States
  • Do Gut Microbiota Contribute to Kidney Disease? If so, What Can We Do About it?
    GrietGlorieux Speaker UGentBelgium
  • What Should Nephrologists Know About Metabolic Dysfunction-associated Fatty Liver Disease
    Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore
  • Measuring Kidney Function in Liver Disease - Pitfalls and Solutions
    SmitaDivyaveer Speaker India
  • Q&A
Amaltas A Hall B101A

Thursday, February 6, 2025

Time Session
9 a.m.
11 a.m.
KenarJhaveri Chair United States
ManishaSahay Chair India
MitchellRosner Chair Univeristy of Virginia HealthUnited States
  • New Solutions to Anemia Management in Kidney Failure: The Role of HIF-PH Inhibitors
    JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland
  • New Solutions to Phosphorus Control in Kidney Failure: Achieving Patient Goals
    KrishnaswamySampathkumar Speaker Meenakshi Mission Hospital India
  • Improving Volume and Hypertension Control in Kidney Failure: New Approaches to a Critical Issue?
    Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore
  • Q and A
Neelkamal Hall 305